“…17,[20][21][22][23][24]34,35 Eleven studies used the hs-cTnT assay as part of their reference standard and were considered as high risk for incorporation bias. [20][21][22][23]25,26,28,31,32,35,36 Seven studies did not exclude STEMI patients, 16,17,25,27,29,30,33 thus raising concerns about applicability. All studies formally re-adjudicated the final diagnoses, except the study by Slagman et al 35 in which the initial clinical diagnosis was used to establish the endpoints.…”